Cell Reports
Volume 12, Issue 9, 1 September 2015, Pages 1391-1399
Journal home page for Cell Reports

Report
PGC-1α Modulates Telomere Function and DNA Damage in Protecting against Aging-Related Chronic Diseases

https://doi.org/10.1016/j.celrep.2015.07.047Get rights and content
Under a Creative Commons license
open access

Highlights

  • PGC-1α disruption promotes vascular aging and atherosclerosis

  • PGC-1α modulates telomere function and length as well as DNA damage

  • High-fat diet reduces PGC-1α-TERT signaling to drive vascular aging and arteriopathy

  • Enabling PGC-1α-modulated TERT and ARE/ERE signaling obviates age-related pathology

Summary

Cellular senescence and organismal aging predispose age-related chronic diseases, such as neurodegenerative, metabolic, and cardiovascular disorders. These diseases emerge coincidently from elevated oxidative/electrophilic stress, inflammation, mitochondrial dysfunction, DNA damage, and telomere dysfunction and shortening. Mechanistic linkages are incompletely understood. Here, we show that ablation of peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) accelerates vascular aging and atherosclerosis, coinciding with telomere dysfunction and shortening and DNA damage. PGC-1α deletion reduces expression and activity of telomerase reverse transcriptase (TERT) and increases p53 levels. Ectopic expression of PGC-1α coactivates TERT transcription and reverses telomere malfunction and DNA damage. Furthermore, alpha lipoic acid (ALA), a non-dispensable mitochondrial cofactor, upregulates PGC-1α-dependent TERT and the cytoprotective Nrf-2-mediated antioxidant/electrophile-responsive element (ARE/ERE) signaling cascades, and counteracts high-fat-diet-induced, age-dependent arteriopathy. These results illustrate the pivotal importance of PGC-1α in ameliorating senescence, aging, and associated chronic diseases, and may inform novel therapeutic approaches involving electrophilic specificity.

Cited by (0)

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).